Home » Authors » Brady Huggett

Articles by Brady Huggett

Pain Therapeutics Raises $49.7M In Follow-On; Neose Getting $23M

Sep. 23, 2003

By Brady Huggett

Pain Therapeutics Raises $49.7M In Follow-On; Neose Getting $23M

Sep. 23, 2003

By Brady Huggett

Antigenics Raising $31.6M Via Stock Sale To Single Investor

Sep. 22, 2003

By Aaron Lorenzo and Brady Huggett

Memory Signs Roche To $150M Expansion Of CNS Collaboration

Sep. 19, 2003

By Brady Huggett

Memory Signs Roche To $150M Expansion Of CNS Collaboration

Sep. 19, 2003

By Brady Huggett

ParAllele, Roche Seek Mutations Associated With Type II Diabetes

Sep. 17, 2003

By Brady Huggett

ParAllele BioScience Inc., as part of its move to the commercial side of things, signed a deal with Hoffmann-La Roche Inc. to discover genes and genetic variations around Type II diabetes. (BioWorld Today)

ParAllele, Roche Seek Mutations Associated With Type II Diabetes

Sep. 17, 2003

By Brady Huggett

ParAllele BioScience Inc., as part of its move to the commercial side of things, signed a deal with Hoffmann-La Roche Inc. to discover genes and genetic variations around Type II diabetes. (BioWorld Today)

Armed With Macugen, Eyetech Joins IPO Queue, Seeks $100M

Sep. 16, 2003

By Brady Huggett

Armed With Macugen, Eyetech Joins IPO Queue, Seeks $100M

Sep. 16, 2003

By Brady Huggett

Tercica, Armed With Genentech Technology, Seeks $86.25M IPO

Sep. 15, 2003

By Brady Huggett